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Iron oxide nanoparticles modified with oleate have been employed for the extraction of
peptides and proteins from aqueous solution before matrix-assisted laser desorption/ioniza-
tion (MALDI) mass spectrometric (MS) analysis. Adsorption of peptides and proteins onto the
nanoparticles were mainly through electrostatic attraction and hydrophobic interaction. The
analyte-adsorbed iron oxide nanoparticles could be efficiently collected from solution using a
magnet. No elution step was needed. With this preconcentration strategy, the lowest
detectable concentration of angiotensin I, insulin, and myoglobin in 500 L of aqueous solution
were 0.1 nM, 0.1 nM, and 10.0 nM, respectively. In addition, the nanoparticles could extract the
analytes from solution with a high content of salt and surfactant, thus eliminating suppression
effect during MALDI MS analysis. This method was successfully applied to concentrate the
tryptic digest products of cytochrome c. In addition, the tryptic digestion of cytochrome c can
be directly conducted on the iron oxide nanoparticles. (J Am Soc Mass Spectrom 2007, 18,
910–918) © 2007 American Society for Mass SpectrometryMatrix-assisted laser desorption/ionization(MALDI) mass spectrometry (MS) has becomea routine analytical tool to determine the
molecular mass of biomolecules [1–3]. However, sam-
ples containing excessive amounts of salts, surfactants,
or other contaminations suffer from ionization suppres-
sion and adduct formation [4, 5]. This limits the appli-
cation of MALDI technique. Therefore, a simple and
selective procedure for extraction and concentration of
analyte from complex samples before MALDI MS is
required.
Various methods have been developed to isolate the
analyte from complex sample matrix. In surface-en-
hanced laser desorption/ionization (SELDI), the sample
target played an active role in the extraction, purifica-
tion, or concentration of the analyte of interest [6 –9].
The target surface was derivatized for the selective
retention of analyte while removing interferences
through on-target washing. Several surface derivatiza-
tions have been designed to extract and concentrate the
analyte through hydrophobic interaction [10, 11], ionic
interaction [12, 13], or immunoaffinity [14, 15]. How-
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doi:10.1016/j.jasms.2007.01.011ever, the sensitivity improvement was limited by the
number of binding sites on the target. In another
approach, the so-called surface-enhanced affinity cap-
ture (SEAC), micrometer-sized beads made for chroma-
tography column were used to capture peptides and
proteins from sample solution [16]. Various types of
beads have been used, which include reverse-phase
chromatographic beads [17, 18] and immobilized metal
ion beads [19 –21]. To speed up the collection of analyte-
adsorbed beads from sample solution, magnetic parti-
cles, which can be simply collected using a magnet,
were developed [22–24]. After collection, the mi-
crobeads were washed and placed on sample target,
followed by analyzing with MALDI MS. Unfortunately,
the presence of those particles on the sample target was
reported to cause decrease in mass accuracy and reso-
lution [25, 26].
Recently, nanoparticles have become interesting
probes for the separation of analyte from sample solu-
tion because of their high surface area-to-volume ratio.
In addition, the interference of nanoparticles during the
laser desorption/ionization process may not exist be-
cause of the smallness of the particles. Previously, C18
functionalized silica nanoparticles have been utilized
for hydrophobic interactions to extract peptides from
acetonitrile, followed by liquid atmospheric pressure
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nanoparticles [28] and diamond [29] were also used to
selectively concentrate positively-charged proteins
through electrostatic interaction. The adsorbed proteins
were then eluted by adding MALDI matrix solution,
such as sinapinic acid (SA) and -cyano-4-hydroxycin-
namic acid (CHCA). An aliquot of the mixed solution
was deposited on sample target for acquisition of mass
spectra. This method allows the MALDI MS detection
of low concentration of proteins in complex matrix
solution. Other types of nanoparticles have also been
used to capture the analytes of interest, such as phos-
phopeptides [30, 31], antigen [32–34], oligonucleotides
[35, 36], aminothiol [37], protein [38, 39], and bacteria
[40, 41]. Among the nanoparticles used, carbon nano-
tube [38], Nile red-adsorbed gold [37], and TiO2-coated
magnetic nanoparticles [30] were not only employed as
affinity probes but also as matrices.
The amount of analytes adsorbed onto the nanopar-
ticles increases with decreasing the diameter of nano-
particles [42]. However, collection of the nanoparticles
with diameter smaller than 10 nm by centrifugation was
not easy. Additionally, the adsorbed analytes may
desorb from the surface of nanoparticles during centrif-
ugation. Magnetic nanoparticles can be easily collected
by using an external magnet. Our goal in this study was
to examine whether the iron oxide nanoparticles
(IONPs) can be used to capture the peptides and
proteins in dilute and complex sample solution. The
surfaces of the iron oxide nanoparticles were modified
with oleate, which contains a long carbon chain and an
anionic carboxylate group. The oleate modified IONPs
can attract positively-charged proteins or peptides
through electrostatic attraction and hydrophobic inter-
action. Then a magnet can be used to isolate the IONPs
quickly from the sample solution. The ability of the
IONPs to act as affinity probes for charged species was
evaluated. The applicability of the method to the pep-
tide residue from the tryptic digest products of cyto-
chrome c was also demonstrated. In addition, the tryp-
tic digestion of cytochrome c can be directly conducted
on the IONPs.
Experimental
Chemicals
Angiotensin I, insulin (from bovine pancreas), cyto-
chrome c (from horse heart), myoglobin (from equine
skeletal muscle), sinapinic acid (SA), ammonium bicar-
bonate, sodium phosphate dibasic, and sodium oleate
were purchased from Sigma (St. Louis, MO). -Cyano-
4-hydroxycinnamic acid (CHCA) was obtained from
Aldrich (Milwaukee, WI). Ferrous chloride tetrahydrate
was purchased from Fluka (Buchs, Switzerland). Iro-
n(III) chloride anhydrous was purchased from
Riedel-de Haën (Seelze, German). Hydrochloric Acid
was purchased from J. T. Baker (Phillipsburg, NJ).
Sodium hydroxide was purchased from Hayashi PureChemical Industries Ltd. (Osaka, Japan). Trypsin was
from Promega (Madison, WI). All chemicals were used
as received without further purification. All other
chemicals were of reagent grade. Water purified with a
Barnstead NANOpure system (Dubuque, IA) was used
for all solutions.
Preparation of IONPs and Surface Modification
Iron oxide nanoparticles in aqueous solution were pre-
pared by a well-known coprecipitation method [43, 44].
Briefly, a reactant solution was prepared by mixing
0.2 g FeCl2 4H2O and 0.34 g FeCl3 into 1.7 mL of
deaerated 0.2 M HCl solution. An aliquot of 160 L of
resulting reactant solution was dropwise added into
200 mL aqueous NaOH solution (0.01 M) under vigor-
ous stirring. The solution mixture was stirred for 30 min
until the black precipitates of iron oxide nanoparticles
formed. Thus prepared iron oxide nanoparticles were
then separated from the solution by using a magnet and
the supernatant was removed from the precipitate by
decantation. The iron oxide nanoparticles were redis-
persed by adding 50 mL deoxygenated deionized water
and the solution was further centrifuged (8000 rpm and
10 min) to obtain flocculates. This purification cycle was
repeated three times to remove excess salts. The redis-
persion of the final flocculates was done by adding 0.01
M HCl aqueous solution (typically 15 mL) with stir to
convert the anionic charges on the nanoparticles into
positive. The resulting cationic colloidal particles were
stabilized because of the positive surface charges, and
the solution appeared black.
The surface modification of the IONPs was then
conducted to attach anionic carboxylate groups onto
iron oxide nanoparticles following the previously re-
ported procedure [45, 46]. This procedure is quite
straightforward: dilute the previously obtained cationic
iron oxide nanoparticles by dissolving 2 mL into 8 mL
HCl solution (0.01 M). Then, 2 mL sodium oleate
solution (0.033 M) was added dropwise into the con-
centration adjusted iron oxide nanoparticles aqueous
solution which was kept at 80 °C with mild stir. The
surface modification reaction was allowed to complete
at least 10 min. A centrifugation followed by redisper-
sion was then performed to remove the excess amount
of oleates. Thus prepared IONPs solution was centri-
fuged by 12,000 rpm for 10 min. The flocculates at the
bottom of ultracentrifugation vial were separated from
the excess amount of sodium oleates by decanting the
upper portion. The flocculates were redispersed into
deionized water and then the final solution was ad-
justed to give its pH value close to 5.
Characterization of IONPs
The shape and size distribution of IONPs were charac-
terized by transmission electron microscope (TEM) us-
ing TEM (JEOL, Tokyo, Japan) at an accelerating 200 kV.
TEM samples were prepared by dipping 200 mesh
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solution. The iron content in the IONP solution was
measured by an atomic absorption spectrometry (AAS).
For such measurements, 10 L of IONP solution mixed
with 990 L of 12 M HCl to convert IONPs into Fe2
solution followed by AAS quantitative analysis
(AA3110; Perkin Elmer, Wellesley, MA). The dissolu-
tion and Fe3/Fe2 transformation required 30 min.
The AAS measurements indicated that the IONPs sus-
pension contained 31.6 mM Fe(II)/Fe(III).
Adsorption Capacity of IONPs
The adsorption capacity of IONPs for peptides and
proteins in 5 mM phosphate buffers at pH 2 to 10 was
investigated. The amount of analytes adsorbed was
determined from the change in analyte concentrations
before and after addition of the IONPs into the solu-
tions. Sixty L of IONPs solution is added to a sample
vial. The magnetic particles in the solution were at-
tracted to the bottom of the sample vial by an external
magnet, and the supernatant solution was removed by
pipet. An aliquot of 1 mL of 105 M analyte solution
was added. The solution mixture was thoroughly
mixed with a shaker for 1 h. After extraction, the
magnetic nanoparticles were collected from the solution
by using a magnet. Quantitation of the analyte concen-
trations was performed by a UV-visible spectroscopy
(Lambda20; Perkin Elmer, Wellesley, MA) at 409 nm for
myoglobin and at 220 nm for insulin and angiotensin I.
Sample Preparation and Extraction Procedure
CHCA and SA solutions, both freshly prepared in
1:1:0.001 acetonitrile/water/TFA solution, were used as
the MALDI matrices for peptides and proteins, respec-
tively. Protein and peptide solutions were prepared in
deionized water and stored at 20 °C. MALDI samples
were prepared by mixing 1 L of analyte solution and
1 L of matrix solution on the target and letting them
dry at room temperature.
Thirty L of IONPs solution was added to a 1.5 mL
vial. The magnetic particles in the solution were at-
tracted to the bottom of the sample vial by an external
magnet, and the supernatant solution was removed by
pipet. Then 500 L of peptide or protein solution was
added to the sample vial. The mixture was thoroughly
mixed with a shaker for 1 h. Again, a magnet was used
to isolate the magnetic nanoparticles from the solution
after extraction. The isolated magnetic nanoparticles
were washed with 100 L of DI water to remove
impurities. Then the collected magnetic nanoparticles
were deposited on a stainless steel target and allowed to
dry. Matrix solution (1 L) was applied on top of the
magnetic particles before MALDI MS analysis. Cyto-
chrome c (1.2 106 M) tryptic digestion [30:1 (wt/wt)]
was performed in a 25 mM NH4HCO3 buffer solution
(pH 7.9) for 24 h at 37 °C. Before extraction, the digestproducts were diluted to desired concentration with
NH4HCO3 buffer solution.
In ZipTip pretreatment, a SCX pipet tip (Millipore,
MA) containing strong cation exchange resin was first
activated by passing through 0.1% TFA aqueous solu-
tion. Then 500 L of peptide or protein solution was
passed through the ZipTip. After rinsing two times
with 10 L of deionized water, the analytes were eluted
with a 0.001:1:1 (vol/vol) TFA-acetonitrile-water mix-
ture (10 L). MALDI samples were prepared by mixing
1 L of elution and 1 L of matrix solution on the target
and letting them dry at room temperature.
MALDI-TOF MS
All the mass spectra were obtained using an Autoflex II
(Bruker Daltonics, Bremen, German) time-of-flight
mass spectrometer equipped with a 1.22 m flight tube.
The samples were irradiated with a 337 nm nitrogen
laser at 10 Hz. The accelerating voltage was set to 19 kV.
The laser energy was 40 to 50 J/pulse. All spectra were
recorded in the positive linear mode except spectra
from the tryptic digestion experiments which were
recorded in the positive reflectron mode (flight length
2.6 m).
Results and Discussion
Adsorption of Peptide and Protein
IONPs were chosen as the extractors in this study
because of their magnetic property and high surface-to-
volume ratios, which facilitate the easy isolation of
analyte-adsorbed nanoparticles from the sample solu-
tion. To prevent nanoparticles aggregation and allow
efficient analyte binding, the surface of IONPs was
modified with oleate, which contains a carboxylate
group and a long carbon chain (C18). Oleate molecules
may trap positively-charged peptides and proteins
through ionic interaction and hydrophobic interaction.
To explore the extraction capability of IONPs, both size
distribution and analytes adsorption were examined
before conducting MS analysis. From the TEM image of
IONPs (data not shown), the IONPs were well dis-
persed and possessed a size distribution of 10.3  1.3
nm. The ability of IONPs to extract angiotensin I,
insulin, and myoglobin from aqueous solution at differ-
ent pH was investigated with UV-VIS absorption spec-
trometry. As shown in Figure 1, the amounts of the
analytes adsorbed were sensitive to the solution pH.
The maximum adsorption occurred at pH 4 for both
insulin (curve b) and angiotensin I (curve a), while the
maximum adsorption for myoglobin (curve c) was at
pH 6. At the optimal pH, the fractions of analytes that
adsorbed to the IONPs were 82, 53, and 70% for insulin,
angiotensin I, and myoglobin, respectively. Based on
these results, the adsorption capacity of the IONPs for
angiotensin I, insulin, and myoglobin were estimated to
be 48 mg/g, 323 mg/g, and 818 mg/g, respectively. The
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myoglobin are 6.9, 5.4, and 6.9, respectively. We found
that the maximum adsorption all occurred when the pH
of the protein solution was below the value of pI. At pH
pI, the protein molecules are positively charged. The
pKa value of the oleic acid is around 5.0. The oleic acid
dissociates into carboxylate, and the surface of IONPs
carries negative charges at pH 4. Therefore, the neg-
atively charged IONPs tend to capture positively
charged protein molecules to their surface through
electrostatic attraction. When the pH of the protein
solution equals the value of pI, 51% of myoglobin
molecules and 15% of insulin and angiotensin I mole-
cules still attach to the surface of IONPs, even without
electrostatic attraction between the protein molecules
and IONPs. The adsorption at pH  pI indicates that
hydrophobic interaction exists between the long carbon
chain of oleate and protein molecules. In addition, the
hydrogen bonding may also involve in the adsorption
process. At pH pI, the fraction of protein molecules
adsorbed to the IONPs rapidly decrease due to the repul-
sive force between the negatively charged protein and the
negative surface of IONPs. The UV-VIS absorption results
suggest that the IONPs can extract peptide and protein
molecules from solution through electrostatic attraction,
hydrophobic interaction, and hydrogen bonding.
Analysis of Peptides and Proteins by MALDI MS
To demonstrate mass spectrometric analysis, angioten-
sin I, insulin, and myoglobin were extracted by IONPs
from solution and analyzed using MALDI MS. In our
method, the collected analyte-adsorbed IONPs were
directly put onto the sample target and 1 L of matrix
solution was added. There is no elution step during
Figure 1. Amounts of (a) angiotensin I, (b) insulin, and (c)
myoglobin adsorbed on nanoparticles as a function of solution
pH. One mL of 105 M analyte solution mixed with 60 L of
IONPs solution. The data were made by averaging three measure-
ments from three separate samples. The relative standard devia-
tions of the measurements were less than 10.0%.sample preparation to alleviate sample transfer lossesand reduce preparation time. Due to the small size of
IONPs, we assumed that the presence of IONPs would
not interfere with desorption and ionization process. To
demonstrate this assumption, 5 L of SA solution
mixed with the protein-adsorbed IONPs and 1 L of the
slurry was used for acquisition of mass spectrum with-
out removal of IONPs. Then the IONPs were collected
Figure 2. Mass spectra of a protein mixture of insulin (5*108 M)
and myoglobin (1*106 M) obtained when using IONPs to trap the
protein for 1 h. The spectra were obtained (a) without and (b) with
removal of the IONPs before MALDI MS analysis. SA was used as
the MALDI matrix.
Figure 3. Mass spectra of a protein mixture of insulin (1*108 M)
and myoglobin (1*106 M) when using IONPs to trap the protein
from buffer of different pH: (a) pH 4, (b) pH 6, and (c) pH 10. SA
was used as the MALDI matrix.
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1 L of the supernatant was analyzed by MALDI MS.
Figure 2 shows the mass spectra of the protein with and
without IONPs. There was no distinct difference in
these two mass spectra. It suggests that the presence of
small IONPs does not deteriorate the signal intensities,
resolution, and mass accuracy of the mass spectra as
shown in Figure 2a. In MALDI, the reproducibility of
intra- and inter-sample was usually poor. We also
examined the reproducibility of the sample preparation.
The signal intensities of angiotensin I, insulin, and
myoglobin varied within 2.5 to 11.8% over 50 sample
spots (five samples).
Figure 1 shows that the adsorption of peptides and
proteins was significantly affected by the pH of the
solutions. We employed a mixture of insulin and myo-
globin to demonstrate the selective capture of protein.
From a solution of pH 4, both insulin and myoglobin
were captured by IONPs, and the adsorbed proteins
were confirmed by MALDI MS (Figure 3a) At pH 6, the
signal intensity for insulin decreased due to the net
negative charges on insulin molecules. However, a
fraction of insulin was still adsorbed to IONPs through
Figure 4. Mass spectra of insulin obtained (a) without any
pretreatment, and (b) with preconcentration of 10 nM, and (c) 0.1
nM insulin solution by IONPs; other conditions as in Figure 2.
Table 1. The signal-to-noise ratios of analytes without and with
Analytes Without pretreatment P
Angiotensin Ia 3.8
Insulina 4.3
Myoglobina 9.6aThe concentrations of angiotensin I, insulin, and myoglobin were 5 nM, 10hydrophobic interaction. From pH 4 to 6, the signal
intensity of myoglobin in the mass spectrum signifi-
cantly increased (Figure 3b), which indicates higher
adsorption of myoglobin at pH 6. These results were
consistent with the results obtained in Figure 1.
The IONPs plays a role as a solid-phase extraction
(SPE) support. The increased surface area-to-volume
ratio of the particle in comparison to microparticles can
allow for efficient extraction and concentration of ana-
lytes from very dilute solution. Figure 4a shows the
mass spectrum of insulin (10 nM) without preconcen-
tration process. The signal/noise (S/N) ratio was deter-
mined to be 4.3. No signals were obtained when the
insulin concentration was lower than 10 nM. With the
use of IONPs to preconcentrate the insulin from 500 L
of solution, the signal was greatly enhanced with S/N
ratio of 63.3 as shown in Figure 4b. Compared with
regular MALDI, mixing 1 L of analyte solution with 1
L of matrix solution, the use of IONPs provides a
15-fold higher peak intensity. With preconcentration by
IONPs, the lowest concentration that can be observed
was 0.1 nM (Figure 4c). The SCX ZipTip, which would
attract positively charged peptide and protein through
electrostatic attraction, was also used to preconcentrate
insulin from 500 L solution (10 nM). The S/N ratio
obtained was 20.3. Compared with the ZipTip result,
the signal intensity obtained by the use of IONPs was
more than three times larger. The same experiments
were performed for myoglobin and angiotensin I, and
the results are summarized in Table 1. The results
indicate that the signal enhancements for the three
analytes are 2- to 3-fold higher when compared to those
with ZipTip. In addition, ZipTip requires more sample
manipulation and increases the possibility of contami-
nation or sample loss. With preconcentration by IONPs,
the lowest detectable concentrations of myoglobin and
angiotensin I were 10.0 nM and 0.1 nM.
Mass Analysis of Peptide and Protein in Complex
Sample Solution
Samples from biological sources often contain a com-
plex mixture of salts and surfactants. However, the
presence of these contaminants will suppress the ana-
lyte signals in MALDI MS. We investigated the ability
of using IONPs to capture analytes and eliminate the
interference from high concentration of salts or surfac-
tants. Figure 5a shows the mass spectrum of insulin and
myoglobin mixture in a sample solution containing
0.1% SDS. Only a very weak signal was observed for
oncentration by IONPs and ZipTip
ncentration by IONPs Preconcentration by ZipTip
32.4 13.6
63.3 20.3
68.9 26.9prec
reconM, and 500 nM, respectively.
solution by IONPs; other conditions as in Figure 2.
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using IONPs to extract insulin and myoglobin from a
solution mixture containing 0.1% SDS, the intense sig-
nals for both insulin and myoglobin were present in the
mass spectrum (Figure 5b). Urea is also frequently
found in protein sample solutions. Figure 5c shows the
mass spectrum of insulin and myoglobin mixture in a
sample solution containing 8 M urea. No insulin or
myoglobin ion was detected. When using IONPs to
extract insulin and myoglobin from a solution mixture
containing 8 M urea, the intense signals for both insulin
and myoglobin were present in the mass spectrum
(Figure 5d). The use of IONPs enhanced the signal
intensities in the presence of the contaminations; how-
ever, the signal intensities were still lower compared
with the analyte solutions of same concentration with-
out salts or surfactants.
The presence of TritonX-100, a nonionic surfactant,
in MALDI samples usually degrades analyte signal.
Figure 6a shows the mass spectrum of angiotensin I
containing 20% TritonX-100. No angiotensin I ion was
detected except a series of TritonX-100 cluster ions
appeared in the mass spectrum. Figure 6b shows the
mass spectrum of angiotensin I after IONPs extrac-
tion. The angiotensin I ion was detected at m/z
1297.67, and the signal at m/z 1359.40 corresponded to
[M  H  Na  K]. Those peaks marked with
asterisks were generated from TritonX-100. Although
slight amount of TritonX-100 was adsorbed onto the
IONPs through hydrophobic interaction, the angio-
tensin I could be efficiently isolated from sample
solution by using IONPs. These results demonstrate
that the analytes can be extracted from contaminated
Figure 6. Mass spectrum of angiotensin I solution containing
20% TritonX-100 obtained (a) without any pretreatment, and (b)
with extraction of mixture solution by IONPs. CHCA was used as
the MALDI matrix.m/z 
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Figure 5. Mass spectra of insulin and myoglobin solution con-
taining 0.1% SDS obtained (a) without any pretreatment, and (b)
with extraction of mixture solution by IONPs. Mass spectrum of
insulin and myoglobin solution containing 8 M urea obtained (c)
without any pretreatment, and (d) with extraction of mixturesample solution by using IONPs and the interference
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veloped procedure provides cleaning and concentra-
tion at the same time.
Mass Analysis of Enzymatic Digest Products
The applicability of the method for analyzing tryptic
digest products of cytochrome c was investigated. Fig-
ure 7a shows the mass spectrum of cytochrome c
Figure 7. Mass spectrum of the tryptic digest products of cyto-
chrome c obtained (a) without preconcentration, (b) with precon-
centration of the digest products (50 L) by IONPs, and (c) with
preconcentration of cytochrome c (500 L), followed by on-
particle enzymatic digestion. CHCA was used as the MALDI
matrix. Peak identities are listed in Table 2.
Table 2. Ions observed in the MALDI mass spectrum of cytochr
database
Peak no. Observed m/z Start-end se
1 1168.67 28-38
2 1296.72 28-39
3 1350.79 89-99
4 1433.85 26-38
5 1470.74 40-53
6 1478.88 89-10
7 1495.77 61-72
8 1598.84 39-53
9 1606.97 88-10
10 1633.69 9-22
11 2081.04 56-72
12 2209.14 56-73aNumber of missed cleavages.(2.5*107 M) tryptic digest products without trapping
by IONPs. There were three low-intensity signals in the
mass spectrum. Figure 7b shows the mass spectrum of
cytochrome c tryptic digest products (5*108 M, 50 L)
after using IONPs to capture the peptide fragments of
digest products. More intense peaks appeared in the
mass spectrum. The ions at m/z 1168.64, 1296.74,
1350.72, 1433.82, 1478.86, 1606.97, 1633.69, and 2209.19
correspond to the enzymatic digest products of cyto-
chrome c, and were confirmed by protein NCBI data-
base searches. The probability-based Mowse score was
126. Signals were enhanced without the need to pre-
separate the enzyme and IONPs from the peptide
fragments for MALDI MS analysis. In another impor-
tant application, IONPs were used to preconcentrate
low concentration of cytochrome c, and the enzymatic
digestion of cytochrome c was conducted directly on
the particles. An aliquot of 500 L cytochrome c solu-
tion (5*108 M) mixed with 10 L of IONPs for 1 h. A
magnet was used to collect the IONPs, and the super-
natant was removed by a pipet. Trypsin in NH4HCO3
buffer solution (2.5 L, 20 ng/L) was added to mix
with the cytochrome c-adsorbed IONPs. The mixture
reacted for 24 h at 37 °C. A magnet was used again to
collect the peptide-adsorbed IONPs, followed by
MALDI analysis. The mass spectrum of on-particle
tryptic digest of cytochrome c is shown in Figure 7c. The
ions at m/z 1168.67, 1296.72, 1350.79, 1433.85, 1470.74,
1478.88, 1495.77, 1598.84, 1633.69, 2081.04, and 2209.14
correspond to the enzymatic digest products of cyto-
chrome c, and were matched by protein NCBI database
searches with a probability-based Mowse score of 170.
Table 2 lists the detailed amino acid sequence. Peak a
(m/z  1230.58) and peak b (m/z  2248.97) were not
matched by NCBI database searches. Peak a may be
caused by the impurity of sample. Peak b was assigned
to be the incomplete digestion fragment, because the
cleavage site on cytochrome c may be blocked by the
adsorption of cytochrome c on the IONPs. This method
integrates isolation, concentration, purification, and di-
gestion on nanoparticles. Compared with the concen-
c tryptic digest and a comparison with the output of the NCBI
ce Missa Peptide sequence
0 TGPNLHGLFGR
1 TGPNLHGLFGRK
1 TEREDLIAYLK
1 HKTGPNLHGLFGR
0 TGQAPGFTYTDANK
2 TEREDLIAYLKK
0 EETLMEYLENPK
1 KTGQAPGFTYTDANK
3 KTEREDLIAYLKK
1 IFVQKCAQCHTVEK
1 GITWKEETLMEYLENPK
2 GITWKEETLMEYLENPKKome
quen
0
0
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mapping, the concentration of cytochrome c used in this
experiment is lower by two orders of magnitude.
Conclusions
We prepared iron oxide nanoparticles modified with
oleate and used them as SPE support to concentrate
peptide and protein from dilute solution. With precon-
centration, the lowest detectable concentration of angio-
tensin I, insulin, and myoglobin were 0.1 nM, 0.1 nM,
and 10 nM, respectively. Sensitivity may be further
enhanced by using a larger volume of sample solution
and a longer extraction time. In addition, the use of
IONPs can eliminate the suppression of analyte signals
due to salts and surfactants in MALDI samples. We
have successfully applied the developed method to the
analysis of enzymatic digest products of proteins. In the
future, the modification of the iron oxide nanoparticle
surfaces can be developed to achieve selective capture
of target biomolecules.
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